471 related articles for article (PubMed ID: 28453551)
21. Genetic polymorphisms in the Toll-like receptor signalling pathway in Helicobacter pylori infection and related gastric cancer.
Castaño-Rodríguez N; Kaakoush NO; Pardo AL; Goh KL; Fock KM; Mitchell HM
Hum Immunol; 2014 Aug; 75(8):808-15. PubMed ID: 24929142
[TBL] [Abstract][Full Text] [Related]
22. The -251T allele of the interleukin-8 promoter is associated with increased risk of gastric carcinoma featuring diffuse-type histopathology in Chinese population.
Lee WP; Tai DI; Lan KH; Li AF; Hsu HC; Lin EJ; Lin YP; Sheu ML; Li CP; Chang FY; Chao Y; Yen SH; Lee SD
Clin Cancer Res; 2005 Sep; 11(18):6431-41. PubMed ID: 16166417
[TBL] [Abstract][Full Text] [Related]
23. Interactions between pork consumption, CagA status and IL-1B-31 genotypes in gastric cancer.
Wang XQ; Terry PD; Cheng L; Yan H; Wang JS; Wu WA; Hu SK
World J Gastroenterol; 2014 Jul; 20(25):8151-7. PubMed ID: 25009387
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-1beta gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms and gastric cancer risk in an Omani Arab population.
Al-Moundhri MS; Al-Nabhani M; Al-Bahrani B; Burney IA; Al-Madhani A; Ganguly SS; Al-Yahyaee SA; Grant CS
Gastric Cancer; 2006; 9(4):284-90. PubMed ID: 17235630
[TBL] [Abstract][Full Text] [Related]
25. Evidences showing association of interleukin-1B polymorphisms with increased risk of gastric cancer in an Indian population.
Kumar S; Kumar A; Dixit VK
Biochem Biophys Res Commun; 2009 Sep; 387(3):456-60. PubMed ID: 19607807
[TBL] [Abstract][Full Text] [Related]
26. The EPIYA-ABCC motif pattern in CagA of Helicobacter pylori is associated with peptic ulcer and gastric cancer in Mexican population.
Beltrán-Anaya FO; Poblete TM; Román-Román A; Reyes S; de Sampedro J; Peralta-Zaragoza O; Rodríguez MÁ; del Moral-Hernández O; Illades-Aguiar B; Fernández-Tilapa G
BMC Gastroenterol; 2014 Dec; 14():223. PubMed ID: 25539656
[TBL] [Abstract][Full Text] [Related]
27. Different effects of polymorphisms of tumor necrosis factor-alpha and interleukin-1 beta on development of peptic ulcer and gastric cancer.
Sugimoto M; Furuta T; Shirai N; Nakamura A; Xiao F; Kajimura M; Sugimura H; Hishida A
J Gastroenterol Hepatol; 2007 Jan; 22(1):51-9. PubMed ID: 17201881
[TBL] [Abstract][Full Text] [Related]
28. Analysis of Pro12Ala PPAR gamma polymorphism and Helicobacter pylori infection in gastric adenocarcinoma and peptic ulcer disease.
Prasad KN; Saxena A; Ghoshal UC; Bhagat MR; Krishnani N
Ann Oncol; 2008 Jul; 19(7):1299-1303. PubMed ID: 18372284
[TBL] [Abstract][Full Text] [Related]
29. Helicobacter pylori cagL amino acid polymorphism D58E59 pave the way toward peptic ulcer disease while N58E59 is associated with gastric cancer in north of Iran.
Cherati MR; Shokri-Shirvani J; Karkhah A; Rajabnia R; Nouri HR
Microb Pathog; 2017 Jun; 107():413-418. PubMed ID: 28433795
[TBL] [Abstract][Full Text] [Related]
30. Genetic polymorphism of cytochrome P450 (CYP) 1A1, CYP1A2, and CYP2E1 genes modulate susceptibility to gastric cancer in patients with Helicobacter pylori infection.
Ghoshal U; Tripathi S; Kumar S; Mittal B; Chourasia D; Kumari N; Krishnani N; Ghoshal UC
Gastric Cancer; 2014 Apr; 17(2):226-34. PubMed ID: 23686565
[TBL] [Abstract][Full Text] [Related]
31. Combination of Helicobacter pylori infection and the interleukin 8 -251 T > A polymorphism, but not the mannose-binding lectin 2 codon 54 G > A polymorphism, might be a risk factor of gastric cancer.
Chang YW; Oh CH; Kim JW; Lee JW; Park MJ; Shim JJ; Lee CK; Jang JY; Dong SH; Kim HJ; Kim SS; Kim BH
BMC Cancer; 2017 May; 17(1):388. PubMed ID: 28558668
[TBL] [Abstract][Full Text] [Related]
32. Variation in human genetic polymorphisms, their association with Helicobacter pylori acquisition and gastric cancer in a multi-ethnic country.
Schmidt HM; Ha DM; Taylor EF; Kovach Z; Goh KL; Fock KM; Barrett JH; Forman D; Mitchell H
J Gastroenterol Hepatol; 2011 Dec; 26(12):1725-32. PubMed ID: 21649724
[TBL] [Abstract][Full Text] [Related]
33. [Peculiarities of genotype distribution of interleukins (IL-1 and IL-10) in patients with peptic ulcer disease and their associations with persistence of Mycoplasma hyorhinis and Helicobacter pylori genotypes].
Abuzarova ER; Gorshkov OV; Chernova OA; Chernov VM; Akberova NI; Abdulkhakov RA
Eksp Klin Gastroenterol; 2008; (6):27-31. PubMed ID: 19334424
[TBL] [Abstract][Full Text] [Related]
34. Influence of interleukin polymorphisms on development of gastric cancer and peptic ulcer.
Sugimoto M; Yamaoka Y; Furuta T
World J Gastroenterol; 2010 Mar; 16(10):1188-200. PubMed ID: 20222161
[TBL] [Abstract][Full Text] [Related]
35. The association between IL-1 family gene polymorphisms and colorectal cancer: A meta-analysis.
Liu L; Zhai Z; Wang D; Ding Y; Chen X; Wang Q; Shu Z; Wu M; Chen L; He X; Fan D; Pan F; Xing M
Gene; 2021 Feb; 769():145187. PubMed ID: 32998046
[TBL] [Abstract][Full Text] [Related]
36. Association between TNFA Gene Polymorphisms and Helicobacter pylori Infection: A Meta-Analysis.
Sun X; Xu Y; Wang L; Zhang F; Zhang J; Fu X; Jing T; Han J
PLoS One; 2016; 11(1):e0147410. PubMed ID: 26815578
[TBL] [Abstract][Full Text] [Related]
37. ASSOCIATION OF IL-8 -251T>A (RS4073) POLYMORPHISM WITH SUSCEPTIBILITY TO GASTRIC CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS BASED ON 33 CASE-CONTROL STUDIES.
Moghimi M; Dastgheib SA; Heiranizadeh N; Zare M; Sheikhpour E; Neamatzadeh H
Arq Gastroenterol; 2020; 57(1):91-99. PubMed ID: 32294742
[TBL] [Abstract][Full Text] [Related]
38. The effects of genetic polymorphisms of IL-6, IL-8, and IL-10 on Helicobacter pylori-induced gastroduodenal diseases in Korea.
Kang JM; Kim N; Lee DH; Park JH; Lee MK; Kim JS; Jung HC; Song IS
J Clin Gastroenterol; 2009; 43(5):420-8. PubMed ID: 19077731
[TBL] [Abstract][Full Text] [Related]
39. Cytokine expressions and H. pylori-associated gastric mucosal lesion.
Takagi A; Deguchi R; Kobayashi K; Miwa T
Keio J Med; 2002 Dec; 51 Suppl 2():51-2. PubMed ID: 12528938
[TBL] [Abstract][Full Text] [Related]
40. Synergistic effect of IL-1β and TNF-α polymorphisms on the H. pylori-related gastric pre-malignant condition.
Tahara T; Shibata T; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Kamiya Y; Ishizuka T; Nakagawa Y; Nagasaka M; Iwata M; Nakamura M; Hirata I; Arisawa T
Hepatogastroenterology; 2012; 59(120):2416-20. PubMed ID: 23169178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
